Rotavirus vs. Sucrose for Vaccine Injection Pain
A Randomized Controlled Trial of Rotavirus Vaccine vs. Sugar Water for Vaccine Injection Pain Management in Infants
1 other identifier
interventional
120
1 country
2
Brief Summary
This randomized trial will compare the analgesic effectiveness of oral rotavirus vaccine to sugar water for reducing vaccine injection pain in infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jun 2014
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 22, 2014
CompletedFirst Posted
Study publicly available on registry
June 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedAugust 15, 2014
August 1, 2014
1.3 years
June 22, 2014
August 13, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distress
Observer rated using the Modified Behavioral Pain Scale (0-10) after each injection and overall
immediately after vaccinations in 15 seconds
Secondary Outcomes (3)
Distress
immediately after vaccinations in 1 minute intervals for 2 minutes
Distress
immediately after vaccinations in 1 minute
Distress
immediately after vaccinations in 1 minute
Other Outcomes (2)
Safety
immediately after vaccinations in 5 minutes
Satisfaction
immediately after vaccination in 1 minute
Study Arms (2)
Sucrose
EXPERIMENTALSucrose prior to vaccine injections
Rotavirus
ACTIVE COMPARATORRotavirus prior to vaccine injections
Interventions
Eligibility Criteria
You may qualify if:
- healthy infants receiving rotavirus vaccine in conjunction with primary immunizations in the first 6 months of life
You may not qualify if:
- impaired neurological development, history of seizures, sedatives or narcotics in preceding 24 hours, parent unable to use study tools, prior participation in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anna Taddiolead
Study Sites (2)
Kindercare
Toronto, Ontario, M5N 1A8, Canada
Anna Taddio
Toronto, Ontario, M5S 3M2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Taddio, PhD
University of Toronto
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 22, 2014
First Posted
June 25, 2014
Study Start
June 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2016
Last Updated
August 15, 2014
Record last verified: 2014-08